Ramified Feline Microglia Selects for Distinct Variants of Feline Immunodeficiency Virus During Early Central Nervous System Infection

References

• Albert SM, Marder K, Dooneief G, Bell K, Sano M, Todak G, Stern Y (1995). Neuropsychologic impairment in early HIV infection. A risk factor for work disability. Arch Neurol 52: 525–530.
   Google Scholar
• Albright AV, Shieh JT, Itoh T, Lee B, Pleasure D, O'Connor MJ, Doms RW, Gonzalez-Scarano F (1999). Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5is the principal coreceptor for human immunodefi-ciency virus type 1 dementia isolates. J Virol 73: 205–213.
   PubMed Web of Science ®Google Scholar
• An SF, Groves M, Gray F, Scaravilli F (1999). Early en-try and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals. J Neuropathol Exp Neurol 58: 1156–1162.
   PubMed Web of Science ®Google Scholar
• Axton RA, Hanson IM, Love J, Seawright A, Prosser J, van Heyningen V (1997). Combined SSCP/heteroduplex analysis in the screening for PAX6 mutations. Mol Cell Probes 11: 287–292.
   Google Scholar
• Back NK, Smit L, De Jong JJ, Keulen W, Schutten M, Goudsmit J, Tersmette M (1994). An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization. Virology 199: 431–438.
   Google Scholar
• Billaud JN, Selway D, Yu N, Phillips TR (2000). Replication rate of feline immunodeficiency virus in astrocytes is envelope dependent: implications for glutamate uptake. Virology 266: 180–188.
   Google Scholar
• Boven LA, Middel J, Verhoef J, De Groot CJ, Nottet HS (2000). Monocyte infiltration is highly associated with loss of the tight junction protein zonula occludens in HIV-1-associated dementia. Neuropathol Appl Neuro-biol 26: 356–360.
   PubMed Web of Science ®Google Scholar
• Boyd MT, Simpson GR, Calm AJ, Johnson MA, Weiss RA (1993). A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism. J Virol 67: 3649–3652.
   Google Scholar
• Carrillo A, Ratner L (1996). Human immunodeficiency virus type 1 tropism for T-lymphoid cell lines: role of the V3 loop and C4 envelope determinants. J Virol 70: 1301–1309.
   Google Scholar
• Chen H, Wood C, Petito CK (2000). Comparisons of HIV-1 viral sequences in brain, choroid plexus and spleen: po-tential role of choroid plexus in the pathogenesis of HIV encephalitis. J Neuro Virol 6: 498–506.
   Web of Science ®Google Scholar
• Cheng-Mayer C, Weiss C, Seto D, Levy JA (1989). Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus. Proc Nail Acad Sci US A 86: 8575–8579.
   Google Scholar
• Clements JE, Babas T, Mankowski JL, Suryanarayana K, Piatak M Jr, Tarwater PM, Lifson JD, Zink MC (2002). The central nervous system as a reservoir for simian im-munodeficiency virus (SW): steady-state levels of SW DNA in brain from acute through asymptomatic infec-tion. J Infect Dis 186: 905–913.de Parseval A, Elder JH (2001). Binding of recombinant fe-line immunodeficiency virus surface glycoprotein to fe-line cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor. J Virol 75:4528–4539.de Ronde A, Stam JG, Boers P, Langedijk H, Meloen R, Hesselink W, Keldermans LC, van Vliet A, Verschoor EJ, Horzinek MC, et al (1994). Antibody response in cats to the envelope proteins of feline immunodeficiency virus: identification of an immuno dominant neutralization do-main. Virology 198: 257–264.
   Google Scholar
• Desrosiers RC, Hansen-Moosa A, Mori K, Bouvier DP, King NW, Daniel MD, Ringler DJ (1991). Macrophage-tropic variants of SIV are associated with specific AIDS-related lesions but are not essential for the development of AIDS. Am J Pathol 139: 29–35.
   Google Scholar
• Dow SW, Dreitz MJ, Hoover EA (1992). Feline immunod-eficiency virus neurotropism: evidence that astrocytes and microglia are the primary target cells. Vet Immunol Immunopathol 35: 23–35.
   Google Scholar
• Dreyer EB, Kaiser PK, Offermann JT, Lipton SA (1990). HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248: 364–367.
   PubMed Web of Science ®Google Scholar
• Ellis RJ, Deutsch R, Heaton RK, Marcotte TD, McCutchan JA, Nelson JA, Abramson I, Thal LJ, Atkinson JH, Wallace MR, Grant 1(1997). Neurocognitive impairmentis an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Arch Neurol 54: 416–424.
   Google Scholar
• Flynn JN, Cannon CA, Reid G, Rigby MA, Neil JC, Jarrett 0 (1995). Induction of feline immunodeficiency virus-specific cell-mediated and humoral immune responses following immunization with a multiple antigenic pep-tide from the envelope V3 domain. Immunology 85: 171–175.
   Google Scholar
• Gabuzda D, Wang J (1999). Chemokine receptors and virus entry in the central nervous system. J NeuroVirol 5: 643–658.
   Web of Science ®Google Scholar
• Gatanaga H, Oka S, Ida S, Wakabayashi T, Shioda T, Iwamoto A (1999). Active HIV-1 redistribution and repli-cation in the brain with HIV encephalitis. Arch Virol 144: 29–43.
   PubMed Web of Science ®Google Scholar
• Ghorpade A, Nukuna A, Che M, Haggerty S, Persidsky Y, Carter E, Carhart L, Shafer L, Gendelman HE (1998a). Human immunodeficiency virus neurotropism: an anal-ysis of viral replication and cytopathicity for divergent strains in monocytes and microglia. J Virol 72: 3340–3350.
   Google Scholar
• Ghorpade A, Xia MQ, Hyman BT, Persidsky Y, NukunaA, Bock P, Che M, Limoges J, Gendelman HE, Mackay CR (1998b). Role of the beta-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 in-fection of monocytes and microglia. J Virol 72: 3351–3361.
   Google Scholar
• Giannecchini S, Matteucci D, Bendinelli M (1998). Effect of enzymatic deglycosylation on feline immunodeficiency virus sensitivity to antibody-mediated neutralization. AIDS Res Hum Retroviruses 14: 199–204.
   Google Scholar
• Giulian D, Vaca K, Noonan CA (1990). Secretion of neuro-toxins by mononuclear phagocytes infected with HIV-1. Science 250: 1593–1596.
   PubMed Web of Science ®Google Scholar
• Gorry PR, Bristol G, Zack JA, Ritola K, Swanstrom R, Birch CJ, Bell JE, Bannert N, Crawford K, Wang H, Schols D, De Clercq E, Kunstman K, Wolinsky SM, Gabuzda D (2001). Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity. J Virol 75: 10073–10089.
   Google Scholar
• Grant I, Atkinson JH, Hesselink JR, Kennedy CJ, Richman DD, Spector SA, McCutchan JA (1987). Evidence for early central nervous system involvement in the ac-quired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Stud-ies with neuropsychologic testing and magnetic reso-nance imaging. Ann Intern Med 107: 828–836.
   Google Scholar
• Gray F, Scaravilli F, Everall I, Chretien F, An S, Boche D, Adle Biassette H, Wingertsmann L, Durigon M, HurtrelB, Chiodi F, Bell J, Lantos P (1996). Neuropathology of early HIV-1 infection. Brain Pathol 6: 1–15.
   PubMed Web of Science ®Google Scholar
• Groenink M, Andeweg AC, Fouchier RA, Broersen S, van der Jagt RC, Schuitemaker H, de Goede RE, Bosch ML, Huisman HG, Tersmette M (1992). Phenotype-associated env gene variation among eight related human immun-odeficiency virus type 1 clones: evidence for in vivo re-combination and determinants of cytotropism outside the V3 domain. J Virol 66: 6175–6180.
   Google Scholar
• Gruol DL, Yu N, Parsons KL, Billaud JN, Elder JH, Phillips TR (1998). Neurotoxic effects of feline immunodefi-ciency virus, FIV-PPR. I NeuroVirol 4: 415–425.
   PubMed Web of Science ®Google Scholar
• He J, Chen Y, Farzan M, Choe H, Ohagen A, Gartner S, Busciglio J, Yang X, Hofmann W, Newman W, MackayCR, Sodroski J, Gabuzda D (1997). CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385: 645–649.
   Google Scholar
• Heaton RK, Velin RA, McCutchan JA, Gulevich SJ, Atkinson JH, Wallace MR, Godfrey HP, Kirson DA, Grant 1(1994). Neuropsychological impairment in human im-munodeficiency virus-infection: implications for em-ployment. HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med 56: 8–17.
   Google Scholar
• Hein A, Martin JP, Dorries R (2001). In vitro activation of fe-line immunodeficiency virus in ramified microglial cells from asymptomatically infected cats. J Virol 75: 8090–8095.
   Google Scholar
• Hein A, Martin JP, Koehren F, Bingen A, Dörries R (2000). In vivo infection of ramified microglia from adult cat cen-tral nervous system by feline immunodeficiency virus. Virology 268: 420–429.
   Google Scholar
• Hwang SS, Boyle TJ, Lyerly HK, Cullen BR (1991). Identifi-cation of the envelope V3 loop as the primary determi-nant of cell tropism in HIV-1. Science 253: 71–74.
   PubMed Web of Science ®Google Scholar
• Janssen RS, Comblath DR, Epstein LG, Foa RP, McArthur JC, Price RW, Asbury AKK, Beckett A, Benson DF, Bridge TP, Leventhal CM, Satz P, Saykin AJ, Sidtis JJ, Tross S (1991). Nomenclature and research case definitions for neurologic manifestations of human immunodefi-ciency virus-type 1 (HIV-1) infection. Report of a Work-ing Group of the American Academy of Neurology AIDS Task Force. Neurology 41: 778–785.
   Google Scholar
• Javaherian K, Langlois AJ, LaRosa GJ, Profy AT, Bolognesi DP, Herlihy WC, Putney SD, Matthews TJ (1990). Broadly neutralizing antibodies elicited by the hyper-variable neutralizing determinant of HIV-1. Science 250: 1590–1593.
   PubMed Web of Science ®Google Scholar
• Johnston JB, Power C (2002). Feline immunodeficiency virus xenoinfection: the role of chemokine receptors and envelope diversity. J Virol 76: 3626–3636.
   Google Scholar
• Johnston JB, Silva C, Power C (2002). Envelope gene-mediated neurovirulence in feline immunodeficiency virus infection: induction of matrix metalloproteinases and neuronal injury. J Virol 76: 2622–2633.
   PubMed Web of Science ®Google Scholar
• Kodama T, Mori K, Kawahara T, Ringler DJ, Desrosiers RC (1993). Analysis of simian immunodeficiency virus se-quence variation in tissues of rhesus macaques with simian AIDS. J Virol 67: 6522–6534.
   Google Scholar
• Koirala TR, Sharma S, Morikawa S, Ishida T (2000). Expres-sion of CXCR4 in the brain of feline immunodeficiency virus infected cat. Indian J Pathol Microbiol 43: 285–290.
   Google Scholar
• Koito A, Stamatatos L, Cheng-Mayer C (1995). Small amino acid sequence changes within the V2 domain can affect the function of a T-cell line-tropic human immunodefi-ciency virus type 1 envelope gp120. Virology 206: 878–884.
   PubMedGoogle Scholar
• Korber BT, Kunstm an KJ, Patterson BK, Furtado M, McEvilly MM, Levy R, Wolinsky SM (1994). Genetic differences between blood- and brain-derived viral se-quences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived se-quences. J Virol 68: 7467–7481.
   PubMed Web of Science ®Google Scholar
• Kuiken CL, Goudsmit J, Weiller GF, Armstrong JS, Hartman S, Portegies P, Dekker J, Cornelissen M (1995). Differ-ences in human immunodeficiency virus type 1 V3 se-quences from patients with and without AIDS dementia complex. J Gen Virol 76: 175–180.
   Google Scholar
• Li Y, Rey-Cuille MA, Hu SL (2001). N-linked glycosylation in the V3 region of HIV type 1 surface antigen modu-lates coreceptor usage in viral infection. AIDS Res Hum Retroviruses 17: 1473–1479.
   PubMed Web of Science ®Google Scholar
• Lombardi S, Garzelli C, La Rosa C, Zaccaro L, Specter S, Malvaldi G, Tozzini F, Esposito F, Bendinelli M (1993). Identification of a linear neutralization site within the third variable region of the feline immunodeficiency virus envelope. J Virol 67: 4742–4749.
   Google Scholar
• Lombardi S, Massi C, Tozzini F, Zaccaro L, Bazzichi A, Bandecchi P, La Rosa C, Bendinelli M, Garzelli C (1995). Epitope mapping of the V3 domain of feline immun-odeficiency virus envelope glycoprotein by monoclonal antibodies. J Gen Virol 76: 1893–1899.
   Google Scholar
• Marcotte TD, Heaton RK, Wolfson T, Taylor MJ, Alhassoon O, Arfaa K, Grant I (1999). The impact of HIV-related neuropsychological dysfunction on driving behavior. The HNRC Group. J Int Neuropsychol Soc 5: 579–592.
   Google Scholar
• McKnight A, Weiss RA, Shotton C, Takeuchi Y, Hoshino H, Clapham PR (1995). Change in tropism upon immune escape by human immunodeficiency virus. J Virol 69: 3167–3170.
   Google Scholar
• Mori K, Ringler DJ, Kodama T, Desrosiers RC (1992). Com-plex determinants of macrophage tropism in env of simian immunodeficiency virus. J Virol 66: 2067–2075.
   Google Scholar
• Nakagaki K, Takahashi K, Schols D, De Clercq E, Tabira T (2001). CXCR4 is the primary receptor for feline immun-odeficiency virus in astrocytes. I NeuroVirol 7: 487–492.
   Google Scholar
• Navia BA, Jordan BD, Price RW (1986). The AIDS dementia complex: I. Clinical features. Ann Neuro119: 517–524.
   Google Scholar
• Nishimura Y, Nakamura S, Goto N, Hasegawa T, Pang H, Goto Y, Kato H, Youn HY, Endo Y, Mizuno T, Momoi Y, Ohno K, Watari T, Tsujimoto H, Hasegawa A (1996). Molecular characterization of feline immunodeficiency virus genome obtained directly from organs of a natu-rally infected cat with marked neurological symptoms and encephalitis. Arch Virol 141: 1933–1948.
   Google Scholar
• Ohagen A, Ghosh S, He J, Huang K, Chen Y, Yuan M, Osathanondh R, Gartner S, Shi B, Shaw G, Gabuzda D (1999). Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: evidence for a role of the envelope. J Virol 73: 897–906.
   Google Scholar
• Page RD (1996). TreeView: an application to display phy-logenetic trees on personal computers. Comput Appl Biosci 12: 357–358.
   PubMedGoogle Scholar
• Pancino G, Fossati I, Chappey C, Castelot S, Hurtrel B, Moraillon A, Klatzmann D, Sonigo P (1993). Structure and variations of feline immunodeficiency virus enve-lope glycoproteins. Virology 192: 659–662.
   Google Scholar
• Pedersen NC, Ho EW, Brown ML, Yamamoto JK (1987). Iso-lation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235: 790–793.
   PubMed Web of Science ®Google Scholar
• Persidsky Y, Zheng J, Miller D, Gendelman HE (2000). Mononuclear phagocytes mediate blood-brain bar-rier compromise and neuronal injury during HIV-1-associated dementia. I Leukoc Biol 68: 413–422.
   PubMed Web of Science ®Google Scholar
• Phillips TR, Talbott RL, Lamont C, Muir S, Lovelace K, Elder JH (1990). Comparison of two host cell range vari-ants of feline immunodeficiency virus. J Virol 64: 4605–4613.
   PubMed Web of Science ®Google Scholar
• Podell M, March PA, Buck WR, Mathes LE (2000). The feline model of neuroAIDS: understanding the progression towards AIDS dementia. I Psych opharma-col 14: 205–213.
   Google Scholar
• Polzer S, Dittmar MT, Schmitz H, Meyer B, Miiller H, Krausslich HG, Schreiber M (2001). Loss of N-linked gly-cans in the V3-loop region of gp120 is correlated to an enhanced infectivity of HIV-1. Glycobiology 11: 11–19.
   Google Scholar
• Power C, Buist R, Johnston JB, Del Bigio MR, Ni W, Dawood MR, Peeling J (1998a). Neurovirulence in feline immun-odeficiency virus-infected neonatal cats is viral strain specific and dependent on systemic immune suppres-sion. J Virol 72: 9109–9115.
   PubMed Web of Science ®Google Scholar
• Power C, Kong PA, Crawford TO, Wesselingh S, Glass JD, McArthur JC, Trapp BD (1993). Cerebral white mat-ter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol 34: 339–350.
   PubMed Web of Science ®Google Scholar
• Power C, McArthur JC, Johnson RT, Griffin DE, Glass JD, Perryman S, Chesebro B (1994). Demented and non-demented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope se-quences. J Virol 68: 4643–4649.
   PubMed Web of Science ®Google Scholar
• Power C, McArthur JC, Nath A, Wehrly K, Mayne M, Nishio J, Langelier T, Johnson RT, Chesebro B (1998b). Neuronal death induced by brain-derived human im-munodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients. J Virol 72: 9045–9053.
   PubMed Web of Science ®Google Scholar
• Pulliam L, Herndier BG, Tang NM, McGrath MS (1991). Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neu-rochemical alterations in cultured human brains. J Gun Invest 87: 503–512.
   PubMedGoogle Scholar
• Richardson J, Pancino G, Merat R, Leste-Lasserre T, Moraillon A, Schneider-Mergener J, Alizon M, Sonigo P, Heveker N (1999). Shared usage of the chemokine recep-tor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus. J Virol 73: 3661–3671.
   Google Scholar
• Rusche JR, Javaherian K, McDanal C, Petro J, Lynn DL, Grimaila R, Langlois A, Gallo RC, Arthur LO, Fischinger PJ, et al (1988). Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc Nail Acad Sci US A 85: 3198–3202.
   PubMed Web of Science ®Google Scholar
• Sabatier JM, Vives E, Mabrouk K, Benjouad A, Rochat H, Duval A, Hue B, Bahraoui E (1991). Evidence for neuro-toxic activity of tat from human immunodeficiency virus type 1.J Virol 65: 961–967.
   Google Scholar
• Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC (2001). HIV-associated neurologic disease incidence changes: Mul-ticenter AIDS Cohort Study, 1990–1998. Neurology 56: 257–260.
   Google Scholar
• Sacktor N, McDermott MP, Marder K, Schifitto G, Seines OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L (2002). HIV-associated cognitive impairment before and after the advent of combination therapy. J NeuroVirol 8: 136–142.
   Google Scholar
• Schonning K, Jansson B, Olofsson S, Hansen JE (1996). Rapid selection for an N-linked oligosaccharide by mon-oclonal antibodies directed against the V3 loop of hu-man immunodeficiency virus type 1. J Gen Virol 77: 753–758.
   Google Scholar
• Sedgwick JD, Schwender S, Imrich H, Dorries R, Butcher GW, ter Meulen V (1991). Isolation and direct character-ization of resident microglial cells from the normal and inflamed central nervous system. Proc Nail Acad Sci USA 88: 7438–7442.
   Google Scholar
• Shieh JT, Albright AV, Sharron M, Gartner S, Strizki J, Doms RW, Gonzalez-Scarano F (1998). Chemokine re-ceptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia. I Virol 72: 4243–4249.
   PubMed Web of Science ®Google Scholar
• Siebelink KH, Karlas JA, Rimmelzwaan GF, Osterhaus AD, Bosch ML (1995). A determinant of feline immunode-ficiency virus involved in Crandell feline kidney cell tropism. Vet Immunol Immunopathol 46: 61–69.
   Google Scholar
• Smit TK, Wang B, Ng T, Osborne R, Brew B, Saksena NK (2001). Varied tropism of HIV-1 isolates derived from different regions of adult brain cortex discrimi-nate between patients with and without AIDS dementia complex (ADC): evidence for neurotropic HIV variants. Virology 279: 509–526.
   PubMed Web of Science ®Google Scholar
• Snider WD, Simpson DM, Nielsen S, Gold JW, Metroka CE, Posner JB (1983). Neurological complications of ac-quired immune deficiency syndrome: analysis of 50 pa-tients. Ann Neuro114: 403–418.
   Google Scholar
• Strizki JM, Albright AV, Sheng H, O'Connor M, Perrin L, Gonzalez Scarano F (1996). Infection of primary human microglia and monocyte-derived macrophages with hu-man immunodeficiency virus type 1 isolates: evidence of differential tropism. J Virol 70: 7654–7662.
   PubMedGoogle Scholar
• Talbott RL, Sparger EE, Lovelace KM, Fitch WM, Pedersen NC, Luciw PA, Elder JH (1989). Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc Nail Acad Sci US A 86: 5743–5747.
   PubMed Web of Science ®Google Scholar
• Tamura K, Nei M (1993). Estimation of the number of nu-cleotide substitutions in the control region of mitochon-drial DNA in humans and chimpanzees. Mol Biol Evol 10: 512–526.
   PubMed Web of Science ®Google Scholar
• Vahlenkamp TW, de Ronde A, Schuurman NN, van Vliet AL, van Drunen J, Horzinek MC, Egberink HF (1999). Envelope gene sequences encoding variable regions 3 and 4 are involved in macrophage tropism of feline im-munodeficiency virus. J Gen Virol 80: 2639–2646.
   Google Scholar
• Vahlenkamp TW, Verschoor EJ, Schuurman NN, van Vliet AL, Horzinek MC, Egberink HF, de Ronde A (1997). A single amino acid substitution in the transmembrane en-velope glycoprotein of feline immunodeficiency virus alters cellular tropism. J Virol 71: 7132–7135.
   PubMed Web of Science ®Google Scholar
• Verschoor EJ, Boven LA, Blaak H, van Vliet AL, Horzinek MC, de Ronde A (1995). A single mutation within the V3 envelope neutralization domain of feline immunod-eficiency virus determines its tropism for CRFK cells. J Virol 69: 4752–4757.
   PubMed Web of Science ®Google Scholar
• Whelan MA, Kricheff II, Handler M, Ho V, Crystal K, Gopinathan G, Laubenstein L (1983). Acquired immun-odeficiency syndrome: cerebral computed tomographic manifestations. Radiology 149: 477–484.
   Google Scholar
• Willett BJ, Flynn JN, Hosie MJ (1997a). FIV infection of the domestic cat: an animal model for AIDS. Immunol Today 18: 182–189.
   PubMedGoogle Scholar
• Willett BJ, Picard L, Hosie MJ, Turner JD, Adema K, Clapham PR (1997b). Shared usage of the chemokine receptor CXCR4 by the feline and human immunodefi-ciency viruses. I Virol 71: 6407–6415.
   PubMed Web of Science ®Google Scholar